Cardiometabolic Health Congress

Healio brings you the highlights from the Cardiometabolic Health Congress. Refer back to this page often for the latest news from CMHC, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News Coverage

Debate focuses on appropriateness of cangrelor, pretreatment with oral antiplatelets in patients undergoing PCI

October 8, 2016
BOSTON — At the Cardiometabolic Health Conference, one expert argued IV cangrelor should be used during PCI and has rendered the practice of…
Meeting News Coverage

Review of CV outcome trials for diabetes drugs shows neutral or positive results

October 7, 2016
BOSTON — At the Cardiometabolic Health Conference, Jay S. Skyler, MD, MACP, from the division of endocrinology, diabetes and metabolism and…
Meeting News Coverage

For SGLT2 inhibitors, big benefits come with some trade-offs

October 7, 2016
BOSTON — The overall profile of sodium-glucose cotransporter 2 inhibitors suggests they are a reliable, second-line therapy choice for adults…
Meeting News Coverage

SPRINT results reinforce connection between hypertension, HF

October 7, 2016
BOSTON — In the SPRINT trial, intensive BP therapy conferred reduced risk for CV events largely through reduction in HF, confirming research…
Meeting News Coverage

Lower BP confers better outcomes, even in patients with diabetes

October 7, 2016
BOSTON — The SPRINT trial and several meta-analyses suggest that more intensive reduction of systolic BP leads to better CV outcomes, but
Meeting News Coverage

Latest advances in hypertension, cardiac care offer new options for patients

October 7, 2016
BOSTON — Several new FDA drug approvals and recent data from both large and small studies offer promising new treatment options for both…
Meeting News Coverage

Experts debate optimal duration of DAPT after MI, stenting

October 6, 2016
BOSTON — Reflecting the wide range of current opinions on dual antiplatelet therapy after MI or coronary artery stenting, two experts at the…
Meeting News Coverage

Updates from new, old diabetes trials shed light on intervention benefits

October 6, 2016
BOSTON — Recent follow-up data from both older and more recent diabetes trials demonstrate the continued, long-term benefits of early…
Meeting News Coverage

Opportunities, challenges shape the landscape of lipid management

October 6, 2016
BOSTON — Advances in genetics and biotechnology have opened the door to new targets and greater speed in the development of lipid-modifying…
Meeting News Coverage

Triglyceride-rich lipoproteins play causal role in CV risk

October 6, 2016
BOSTON — Several new insulin therapies are anticipated for patients with diabetes in 2017; however, for many, cost may put the latest options